| Dr Porter’s Natural History Trial in America – the Merits of AttendingOur son, William, was diagnosed with NPC just over 5 years ago at the age of 9 months. Ever since the diagnosis, we have been strong believers in the merits of developing a database containing relevant information about the progress of the disease in patients with NPC. Therefore we were very excited to read about the natural history trial by Dr Forbes Porter in America. (“Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, type C”)..... | New European Task Force on Brain and Neurodegenerative Lysosomal Storage Disorders (LSDs) The mission of Brains for Brain is to catalyse research in the field of neurodegeneration and lysosomal diseases. Brains for Brain is formed as an association of highly distinguished scientists and clinicians working together to create and coordinate effort towards the comprehension of the pathophysiology processes of neurological disorders occurring in lysosomal storage disorders....Read more |
Research News
Who could resist free trips to
New
York City while helping kids at the same time?
Hello
from Anne OConnor-Smith in
Florida! I would like you all to be aware that Genzyme
Corporation is currently recruiting adults with Niemann-Pick Type B to participate
in a single dose study of lab-created enzyme rhASM to be administered at
Mt.
Sinai
Hospital in
New
York City. This
study needs 15 patients but only has 9 signed up so far and so the study is now
accepting patients from the
UK
and
Germany. For further information, please contact
Genzyme Medical Information or Jackie Imrie on 0161 922 2414 (email
jackie.imrie@cmmc.nhe.uk). Two links
describing the study are listed below:
http://www.nnpdf.org/npresearch_11.html
http://www.clinicaltrials.gov/ct/show/NCT00410566?order=1
At
age 41, I was patient #6 in this study and I want to impress upon others the
importance of volunteering for this study. Upon successful completion of this study, a second study is planned that
will accept children and will administer multiple doses of the enzyme that
could be approved as treatment for NPD-B. Genzyme has prior experience with enzyme replacement as their company
researched, produced, and had approved an enzyme currently given intravenously every two weeks for patients
with Gaucher’s disease that can dramatically decrease liver and spleen size, reduce skeletal abnormalities,
and reverse other manifestations. Two
related links are listed below:
http://en.wikipedia.org/wiki/Gaucher%27s_disease
http://en.wikipedia.org/wiki/Imiglucerase
The
study requires 4 visits to
Mt.
Sinai Hospital
which is in downtown
New York City directly
across from
Central Park and within walking
distance of several museums. Genzyme
pays the airfare for the patient and for some visits, also pays airfare for a
companion. The hospital is a short subway ride away from Broadway musicals,
Times Square, and many other attractions. Except for the infusion visit, I was able to
leave the hospital on some evenings to explore
New York. On one visit, I took a longer ride and saw the Statue of Liberty and the
New York Stock Exchange. Several delis
and restaurants are within walking distance and my favourites are:
http://www.onefishtwofish.com/
http://www.seattlecafe.com/
Upper East Side
location, 1411
Madison Ave @ 98th St.
The
first visit is the baseline visit and lasts about three days. During this visit, several tests are taken to
determine if the patient qualifies for the study. A scan is used to accurately measure spleen
and liver size and tests are run to determine lung function. A skin and a liver biopsy are performed on
the last day. I didn’t think that I would qualify for the
study because I didn’t think my spleen was at least 2 times normal size since
no doctor during my adult lifetime has felt an enlarged spleen. Scans provide more information and I found
out that my spleen is 8.5 times normal size and my liver is about 1.2 times
normal. I had no liver cirrhosis so I
qualified for the study.
It
can take a week to get all the test results back and once qualified for the
study, the patient has some time to decide when to come back for the
infusion. During the infusion visit the
patient stays at the hospital and starts out in the cardiac care unit. The first night the patient is monitored to
determine their normal heart rhythms and then the infusion is given in the
morning. The cardiac care unit was noisy
so I would recommend ear plugs. The
patient is on a monitor but there is a small toilet and sink so the patient can
get out of bed for that. Except for the
needle insertion, the enzyme infusion is painless. Nurses and doctors closely monitored me and
I didn’t have any ill effects. I had
brought books, there was a TV in the room, and my mother was there to talk
to. They did take a lot of blood samples
during that day. Later I was given a
portable monitor and I was able to go back to the research center hospital
room.
The
third visit must occur 14 days (+-2 days) after the infusion so the schedule needs
to be worked out carefully in advance. I
told my supervisor about the study and he was flexible with my time off. I took sick time and also made up some of the
time by working extra hours. On the
third visit, the same tests taken during the baseline visit are repeated. I asked for a light sedative the second time
before the liver biopsy as I had some associated nerve pain after the first
biopsy that caused pain in my chest and right arm. The first liver biopsy actually hurt for a
few days but the second biopsy did not cause any pain afterwards.
The
final visit must occur 28 days (+- 2 days) after the infusion, it is the
shortest visit and only includes a blood draw and a physical exam. My final visit was September 4, 2007 and no
problems were found. I have been feeling
fine after the study and I have since been on two 61 mile bikes rides, two 31
mile bike rides, two 8 mile runs and one 10 mile run. Read on if you want to know more about my
history and why this type of exercise is not unusual for me.
To
introduce myself, I am a healthy 41 year-old female athlete, I work full-time,
I have obtained a master’s degree, I have three children, three step-children,
and a step-grandchild. I have completed
six marathons, 17 triathlons, earned various belts in Aikido, and received
awards in running and Kung Fu events. I
am training for the MiamiMan half ironman triathlon in November 2006 (race info
at http://www.multirace.com/MiamiMan/).
My
medical background might help explain why such a healthy woman would be
included in a NPD study. As a child
living in Louisiana,
I had been complaining of stomach ache and having trouble sitting in school
because of the pain. My paediatrician noticed that my spleen was enlarged and he referred my family to specialists in
Texas. At the age of 11, I was diagnosed with NPD
Type B and sea-blue histiocytes at Texas Children's Hospital. I was told I was
about to die as the doctors mistakenly thought I had Leukemia and later thought
I had NPD Type C. When they realized I had NPD Type B, they said they did not
know what would happen to me. My younger
sister, Margo, also has Type B and my brother, Ryan, is a carrier. We have
reduced ASM levels but have been very healthy all our lives, with only minor
issues, and we did not continue to be monitored for the disease. The hospital offered to examine us annually
for free but after a week long barrage of tests and the trauma of misdiagnosis,
I refused to go back!
Unfortunately,
I had it in my head that I was dying for years after being misdiagnosed. I had to drop out of gymnastics because I was
not allowed to use the parallel bars and I had a note for gym class that I
could not be involved in contact sports. However, I continued to be very active
since we lived in the country, we had a little dog who loved to run outside,
and we had our own large swimming pool. Some doctors wanted to remove my spleen as they feared it would rupture
but they also said that once I started growing there might be more room for it.
My parents did not let them remove it and I am happy about that since I have
heard that people with NPD-B without a spleen can have more severe lung
complications.
In
my adult life, I decided I was healthier than most people my age and that I
should focus on living and stop worrying so much about dying. I did not discuss the disease even with
doctors. Every time I went for my annual
physical and the doctor would feel my abdomen, I would worry that they would
find that my spleen was still enlarged but they never commented so I assumed it
was normal size. At age 33, I started martial arts as I assumed there was no
longer any issue with my participating in contact sports. I have since told my instructors that I can
no longer participate in sparring or throws but I continue to work individually
on my forms.
Before
my sister had her first baby, her husband went through genetic testing and she
tried to get me more interested in finding out more about NPD-B but I still did
not want to think about it. Then in
February 2007, I started researching NPD online and I joined the typeb-nnpdf
Yahoo group. After reading about others
who have worse symptoms than me, reading about the clinical trail, seeing the
pictures of the first volunteer, Brice age 22, and reading about the third
volunteer, Kevin (Brice’s brother) age 19, I decided I should volunteer.
Through
specialized testing at Mt. Sinai, I found out that I have a spleen size 8.5
times normal, liver size 1.2 times normal, and cholesterol build up in my
heart, lungs and gallbladder. However,
my lung functioning is normal. My other
symptoms include weakness and fatigue due to anemia, easy bruising, joint pain,
thinning bones, repeated respiratory infections, intolerance of cold temperatures,
and reduced coordination. Overall I am
blessed with enough health to continue as an athlete.
Now
I am trying to get the word out for more study volunteers. Please spread the word. I looked at my medical records from 30 years
ago and the doctors mentioned that enzyme replacement therapy was
experimental. How sad it is that is has
taken that long to finally arrive at human studies for the enzyme rhASM for
NPD-B patients. So many parents have
been praying through the years for a treatment and we are now on the brink, but
we need adults with NPD-B to step forward and volunteer for this study so we
can move closer to an approved treatment for NPD-B. For further information, please contact
Genzyme Medical Information Information or Jackie Imrie on 0161 922 2414 (email
jackie.imrie@cmmc.nhe.uk).
If
anyone wants to contact me directly, feel free to email me at
healthnutgirl@hotmail.com.

